Day: April 24, 2020

Midlertidig ændring af emissions- og indløsningssatser justeres tilbage til normal satserPortefølje Administration A/S monitorerer løbende aktuelle markedsforhold og har vurderet, at de midlertidige ændringer af emissions- og indløsningssatser for nedenstående afdeling justeres tilbage til normaliserede satser. Nykredit Portefølje Administration A/S monitorerer fortsat løbende aktuelle markedsforhold. Afdelingerne og %-satserne er angivet nedenfor:Eventuelle spørgsmål vedrørende denne meddelelse kan rettes til adm. direktør Martin Udbye Madsen, tlf. 44 55 86 45.Med venlig hilsenNykredit Portefølje Administration A/SMartin Udbye Madsen, adm. direktørVedhæftet filFondbørsmeddelelse – Ændring af spreads – 23. april 2020 – Investin

Midlertidig ændring af emissions- og indløsningssatserNykredit Portefølje Administration A/S har foretaget en midlertidig ændring af i forvejen forhøjet emissions- og indløsningssatser, således at emissions- og indløsningssatserne nedsættes for afdelinger i nedenstående tabel. Nykredit Portefølje Administration A/S monitorerer løbende aktuellemarkedsforhold og har vurderet, at de nuværende markedsforhold giver anledning til at justere emissionstillæg og indløsningsfradrag. Afdelingerne og %-satserne er angivet nedenfor:Når der igen vendes tilbage til emissions- og indløsningssatsers i henhold til prospektet vil der blive meddelelse herom.Eventuelle spørgsmål vedrørende denne meddelelse kan rettes til adm. direktør Martin Udbye Madsen, tlf. 44 55 86 45.Med venlig hilsenNykredit Portefølje Administration A/SMartin Udbye Madsen, adm. direktørVedhæftet...

VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company is pleased to announced that its license partner, CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS“) filed an application with the U.S. Food and Drug Administration (“FDA”) under the Orphan Drug Act to receive Orphan Drug Designation (“ODD”) for its brain cancer drug candidate, Berubicin. WPD was previously awarded a reimbursement grant of approximately $6 million by the Polish National Center for Research and Development for a Phase 2 study of Berubicin, in Poland.Under a prior developer, Berubicin, then known as RTA 744, was granted ODD by the FDA for the treatment of malignant gliomas. In the prior developer’s Phase 1 trial of Berubicin,...

VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc.  (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is pleased to announce its wholly owned subsidiary Sustainable Growth Strategic Capital Corp. (“SGSC” or “the Company”) a federally licensed cannabis company based in the Greater Toronto Area (“GTA”) has successfully produced the first full run of full spectrum winterized CBD crude oil (“CBD Oil”) and CBD distillate.SGSC is focused on taking advantage of the underserviced market for CBD Oil, CBD Distillate and CBD Isolate by crafting partnerships to generate revenue while limiting fiscal and operational risk. SGSC has previously partnered with Micro C45 Inc. (“MC45”), a Canadian company that has developed a unique post-harvest mechanical separation process...

SCANFIL OYJ      PÖRSSITIEDOTE    24.4.2020     KLO 9.45Hallituksen päätöksen perusteella omien osakkeiden hankinta päättyy viimeistään seuraavaan varsinaiseen yhtiökokoukseen, kuitenkin viimeistään 30. kesäkuuta 2021. Omia osakkeita voidaan hankkia ohjelman puitteissa vielä yhteensä 145 309 kappaletta. Osakkeiden hankintaan käytetään yhteensä enintään 1,4 miljoonaa euroa. Osakkeet hankitaan Nasdaq Helsinki Oy:n julkisessa kaupankäynnissä hankintahetken markkinahintaan.  Hankittavia osakkeita käytetään yhtiön avainhenkilöiden optio-ohjelmiin liittyvien velvoitteiden täyttämiseksi.Yhtiön hallitus päätti 9.3.2020 käyttää varsinaisen yhtiökokouksen 24.4.2019 antamaa valtuutusta hankkia omia osakkeita. Hankittavien osakkeiden yhteismäärä oli enintään 300 000 osaketta mikä vastaa noin 0,5 % osakkeiden kokonaismäärästä. Hallituksen päätöksen...

SCANFIL PLC     STOCK EXCHANGE RELEASE   24 APRIL  2020      9.45 A.M.Scanfil Oyj’s Board of Directors has today, on 24 April 2020 decided to continue to repurchase the Company’s own shares based on the authorization given by the Annual General Meeting held on 23 April 2020. The repurchases are part of the share repurchase program initiated on 9 March 2020.Based on the decision made by the Board of Directors, the repurchasing of shares will end by the next Annual General Meeting at the latest, however no later than 30 June 2021. As part of the share repurchaseprogram a total of 145,309 shares can still be repurchased. The maximum amount of euros to be used for the repurchase is total EUR 1.4 million. The shares will be repurchased in public trading on the Nasdaq Helsinki Ltd at the market price prevailing at the time of repurchase. The...

AS Tallink Grupp will introduce the results of the first quarter of 2020 in an investor webinar. All shareholders and other stakeholders are invited to join the webinar, scheduled to take place on 8 May 2020 at 10:00 (EET). The webinar will be held in English and prior registration is required.The financial results will be presented by the Chairman of the Management Board Paavo Nõgene, Member of the Management Board Harri Hanschmidt and Financial Director Veiko Haavapuu. We kindly ask participants to provide their questions before the webinar, latest by 7 May, by e-mail to: investor@tallink.ee. Due to time constraint, preference will be given to questions submitted in writing before the webinar.How to join the webinar?To join the webinar, please register by 8 May 2020 at 9:30 (EET) latest via the following link: https://attendee.gotowebinar.com/register/63957898090440203.When...

AS Tallink Grupp kutsub aktsionäre ning teisi huvilisi osalema 2020. aasta esimese kvartali tulemusi tutvustaval veebiseminaril 8. mail 2020 kell 10:00 (EET). Veebiseminar toimub inglise keeles ning vajalik on eelnev registreerimine.Majandustulemusi tutvustavad juhatuse esimees Paavo Nõgene, juhatuse liige Harri Hanschmidt ning finantsdirektor Veiko Haavapuu. Küsimused palume saata enne veebiseminari toimumist hiljemalt 7. maiks e-kirja teel: investor@tallink.ee. Ajalisest piirangust tulenevalt käsitletakse enne veebiseminari kirjalikult saabunud küsimusi eelisjärjekorras.Kuidas veebiseminaril osaleda?Veebiseminaril osalemiseks palume registreeruda hiljemalt 8. mail kell 9:30 (EET): https://attendee.gotowebinar.com/register/63957898090440203.Kui osalete veebiseminaril esimest korda, palutakse alla laadida vajalik rakendus. Juhul kui rakenduse...

Good morning,Please find below the press release issued today.Best regards,Michele Moore DuhenGlobal PR Manager | Group Marketing & CommunicationsCapgemini Group | LondonTel.: +44 3709 053408Email: Michele.MooreDuhen@capgemini.com_____________________________Press Relations:Sam ConnattyTel.: +44 370 904 3601Email: sam.connatty@capgemini.comCapgemini reinforces its commitment to the global fight against COVID-19New Social Response Unit to mobilize and scale key initiatives with primary focuson public health  Paris, April 24, 2020 – Capgemini today affirmed its commitment to the global fight against COVID-19, by detailing a series of initiatives being undertaken across the Group. Capgemini colleagues have mobilized strongly, expressing their solidarity and leveraging their creative and deep technology and data expertise, to address...

Bonjour,Vous trouverez ci-après le communiqué de presse diffusé ce jour.Bien cordialement,Florence LièvreGlobal PR Manager | Group Marketing & CommunicationsCapgemini Group | ParisTel.: +33 1 47 54 50 71Email : florence.lievre@capgemini.com_____________________Contact presse :Florence LièvreTél. : 01 47 54 50 71E-mail : florence.lievre@capgemini.comCapgemini renforce son engagement dans la lutte mondialecontre le COVID-19Le Groupe mobilise ses forces à travers le monde pour déployer une série d’initiatives à impact social, mettant en priorité la santé publique, pilotées par un nouveau comité ‘Social Response’.Paris, le 24 avril 2020 – Capgemini affirme aujourd’hui son engagement dans la lutte mondiale contre COVID-19, en présentant une série d’initiatives menées au sein du Groupe. Solidaires avec les efforts déployés...